Evaluation of Lassa antiviral compound ST-193 in a guinea pig model

Lassa virus (LASV), a member of the Arenaviridae family, causes a viral hemorrhagic fever endemic to West Africa, where as many as 300,000 infections occur per year. Presently, there are no FDA-approved LASV-specific vaccines or antiviral agents, although the antiviral drug ribavirin has shown some...

詳細記述

保存先:
書誌詳細
主要な著者: Cashman, Kathleen A., Smith, Mark A., Twenhafel, Nancy A., Larson, Ryan A., Jones, Kevin F., Allen, Robert D., Dai, Dongcheng, Chinsangaram, Jarasvech, Bolken, Tove’ C., Hruby, Dennis E., Amberg, Sean M., Hensley, Lisa E., Guttieri, Mary C.
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier B.V. Published by Elsevier B.V. 2011
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3319460/
https://ncbi.nlm.nih.gov/pubmed/21371508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2011.02.012
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料